Bioconjugated Thymol-Zinc Oxide Nanocomposite as a Selective and Biocompatible Antibacterial Agent against Staphylococcus Species
Open Access
- 17 June 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (12) , 6770
Abstract
Owing to the rapid spread of antibiotic resistance among Staphylococcus species, effective and low-risk alternatives to antibiotics are being actively searched. Thymol (THO), the most abundant component of the oil extracted from thyme, can be considered as a natural antibacterial alternative. However, the low antibacterial activity and non-selectivity of THO limit its usage as a universal anti-Staphylococcus agent. Herein, we report the bioconjugation of THO with ZnO nanoparticle (ZO), which resulted in the TZ nanocomposite (NC), as a potent and selective antibacterial agent against Staphylococcus species, particularly S. epidermidis. The cell-free supernatant (CFS) of ATCC 25923 cultures was employed for the production of TZ NC. Successful production of TZ NC was confirmed via X-ray diffraction (XRD), Fourier-transform infrared (FT-IR) spectroscopy, and ultraviolet–visible (UV–Vis) studies. TZ NC had selective efficacy against Staphylococcus species, with MIC values 2–32-fold lower than THO. The antibacterial mechanisms of TZ NC are proposed to involve membrane rupture, suppression of biofilm formation, and modulation of new cell wall and protein-synthesis-associated cellular pathways. Its biocompatibility against HCT116 cells was also checked. Our findings suggest that the TZ nanocomposite could improve the selectivity and bactericidal activity of THO against target species.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2021R1A2C1007413)
This publication has 49 references indexed in Scilit:
- Comparative Study on the Synergistic Action of Differentially Synthesized Silver Nanoparticles with β-Cephem Antibiotics and ChloramphenicolJournal of Nanoscience, 2014
- Fungal biosynthesis of gold nanoparticles: mechanism and scale upMicrobial Biotechnology, 2014
- Nanoparticles for Combination Drug TherapyACS Nano, 2013
- Escherichia coli YmdB regulates biofilm formation independently of its role as an RNase III modulatorBMC Microbiology, 2013
- Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugsJournal of Applied Oral Science, 2012
- Selective toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis through lipid peroxidationNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Linezolid, the first oxazolidinone antibacterial agentAnnals of the New York Academy of Sciences, 2011
- Staphylococcus epidermidis — the 'accidental' pathogenNature Reviews Microbiology, 2009
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substancesNature Protocols, 2008
- Biological synthesis of silver nanoparticles using the fungus Aspergillus flavusMaterials Letters, 2007